The Search for Signals: How Diabetes Biomarker Research Is Using C-Peptide Antibodies
The advancement of diabetes research relies on the identification and study of reliable biomarkers, and Diabetes biomarker research extensively utilizes C-peptide antibodies. The global C-peptide antibody market, valued at USD 500 million in 2025 and projected to grow to USD 1.5 billion by 2035, is a testament to the importance of these tools in understanding the pathophysiology of...
0 Comments 0 Shares 14 Views 0 Reviews